Research News LRF Announces Research Grants in Mantle Cell Lymphoma, Lymphoma Clinical Research Mentoring Program
Lymphoma News U.S. Food and Drug Administration Approves Pembrolizumab (Keytruda) for Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma (PMBCL)
Research News Lymphoma Research Foundation Adherence in Oral Therapies Scientific Meeting Featured in ASCO Post
Lymphoma News U.S. Food and Drug Administration Approves Venetoclax (VENCLEXTA) For Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia – With or Without 17p Deletion
LRF News Lymphoma Research Foundation (LRF) Awards More Than $1.3 Million in Research Grants for 2018
LRF News Past and Present LRF Scientific Advisory Board Members Honored with Prestigious National Awards for Leadership in Cancer Research
Lymphoma News U.S. Food and Drug Administration Approves Tisagenlecleucel For Relapsed/ Refractory Large B-cell Lymphoma
Lymphoma News U.S. Food and Drug Administration Approves Brentuximab Vendotin For Frontline Hodgkin Lymphoma
